Effect of Varied Outreach Methods on Appointment Scheduling and Appointment Completion Using MyChart

August 8, 2024 updated by: Children's Hospital Medical Center, Cincinnati
Our objective is to determine the effectiveness of varied outreach methods (e.g. standard versus tailored MyChart messaging) to children age 6-17 years old who are due for a WCC visit and don't have one scheduled in the next 45 days on the outcomes of appointment scheduling and appointment completion.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

945

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Ohio
      • Cincinnati, Ohio, United States, 45229
        • Cincinnati Children's Hospital Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 17 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • age 6-17 years
  • has not had a well child check in past 365 days
  • no future well child check visit scheduled
  • parent preferred language = English or Spanish

Exclusion Criteria:

  • no active MyChart account

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: No message
No message sent
Other: No Message
No messages are sent
Active Comparator: Standard message
2 MyChart reminders that child is overdue for well child check visit
Other: Standard message
2 MyChart reminders that child is overdue for well child check visit
Active Comparator: Tailored message
2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age
Other: Tailored message
2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants Who Completed Well Child Check Visit
Time Frame: Within 8 weeks of the date of intervention or the date of randomization for the control group
Participants completed well child check visit as determined by presence of a well visit billing code documentation in the electronic health record.
Within 8 weeks of the date of intervention or the date of randomization for the control group

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants Who Scheduled an Appointment for a Well Child Check Visit.
Time Frame: Within 8 weeks of the date of intervention or the date of randomization for the control group
Participant scheduled a well child check visit as determined by electronic health record documentation.
Within 8 weeks of the date of intervention or the date of randomization for the control group
Number of Participants Who Received Their First COVID-19 Vaccination
Time Frame: Within 8 weeks of the date of the intervention or the date of randomization for the control group
Participant receipt of their first COVID-19 vaccination as determined by presence of documentation of vaccine administration in the electronic health record.
Within 8 weeks of the date of the intervention or the date of randomization for the control group

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Children's Hospital Medical Center, Cincinnati

Investigators

  • Principal Investigator: William Brinkman, MD, Cincinnati Children's

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 30, 2021

Primary Completion (Actual)

October 7, 2021

Study Completion (Actual)

February 28, 2022

Study Registration Dates

First Submitted

July 29, 2021

First Submitted That Met QC Criteria

July 29, 2021

First Posted (Actual)

August 6, 2021

Study Record Updates

Last Update Posted (Actual)

August 28, 2024

Last Update Submitted That Met QC Criteria

August 8, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2020-0769-2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Care Utilization

Clinical Trials on No Message

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe